Bedsore Solutions CO is categorized under Patent Medicines in Torrance, CA and active since 2000.
Bedsore Solutions CO was established in 2000, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Patent Medicines business, which does work in the B2B market, and is classified as a Patent Medicines, under code number 6213990 by the NAICS.
If you are seeking more information, feel free to contact Martin Morsett, Owner at the company’s single location by writing to 2907 Dalemead St, Torrance, California CA 90505 or by phoning (310) 326-4209. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Bedsore Solutions CO |
| Contact Person: | Martin Morsett, Owner |
| Address: | 2907 Dalemead St, Torrance, California 90505 |
| Phone Number: | (310) 326-4209 |
| Website Address: | bedsoresolutions.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2000 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Patent Medicines |
| SIC Code: | 5122 |
| NAICS Code: | 6213990 |
| Share This Business: |
Bedsore Solutions CO was started in 2000 to provide professional Patent Medicines under the SIC code 5122 and NAICS code 6213990. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Martin Morsett, Owner for inquiries that concern Bedsore Solutions CO by calling the company number (310) 326-4209, as your correspondence is most welcome. Additionally, the physical location of the single location of Bedsore Solutions CO can be found at the coordinates 33.793674,-118.338944 as well as the street address 2907 Dalemead St in Torrance, California 90505.
For its online presence, you may visit Bedsore Solutions CO’s website at bedsoresolutions.com and engage with its social media outlets through on Twitter and on Facebook.